Pharmaceutical Medical Director Pleads Guilty To Misbranding Suboxone Film Drug
The former global medical director of a pharmaceutical company pleads guilty in Abingdon U.S.District Court to causing the introduction into interstate commerce, of the opioid drug Suboxone Film. Timothy Baxter former global medical director of Indivior admitted he supervised and sent inaccurate drug safety information to a Medicaid agency. Baxter oversaw reports and graphs that were omitted or falsified. Baxter was the top medical executive of Indivior , formely known as Reckitt Benckiser Pharmaceuticals from 2000 to 2016. The company previously paid more than one million dollars to resolve its liability in the case and current Indivior Pharmaceuticals has agreed to pay 600 million dollars to resolve its criminal and civil liabilities.